Fundraising Fox

Potenza Therapeutics

Cambridge, US · Founded 2013 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

CS
Cynthia Seidel-DuganExecutive
DC
David CordoExecutive
DH
Daniel HicklinExecutiveManaging Partner at MPM Capital
RL
Reid LeonardExecutive

Board

AO
Arnold OronskyBoard director
LELuke Evnin
Luke Evninin𝕏Board directorAdvisor at MPM BioImpact
SA
Sakae AsanumaBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$35M disclosed across 2 rounds · 2014–2017

$5MraisedDec 2017 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Shunichiro MatsumotoDirector
  • Luke EvninDirector
  • Cynthia Seidel-DuganExecutive Officer
  • Reid LeonardExecutive Officer
  • Daniel HicklinExecutive Officer, Director
  • Arnold OronskyDirector
  • David CordoExecutive Officer
Offering amount
$5M
Amount sold
$5M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$30MraisedMar 2016 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Cynthia Seidel-DuganExecutive Officer
  • David CordoExecutive Officer
  • Daniel HicklinExecutive Officer, Director
  • Arnold OronskyDirector
  • Reid LeonardExecutive Officer
  • Luke EvninDirector
  • Sakae AsanumaDirector
Offering amount
$38M
Amount sold
$30M
First sale
Dec 2014
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Potenza Therapeutics went on to found or lead other companies.

Frequently asked questions

Who are Potenza Therapeutics's investors?
Potenza Therapeutics's investors include MPM BioImpact.
How much funding has Potenza Therapeutics raised?
Potenza Therapeutics has disclosed $35M raised across 2 rounds.
Where is Potenza Therapeutics headquartered?
Potenza Therapeutics is headquartered in Cambridge, US.